| 000 | 01844 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250518010538.0 | ||
| 264 | 0 | _c20200611 | |
| 008 | 202006s 0 0 eng d | ||
| 022 | _a1872-6240 | ||
| 024 | 7 |
_a10.1016/j.brainres.2018.11.018 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHe, He | |
| 245 | 0 | 0 |
_aBone marrow mesenchymal stem cell transplantation exerts neuroprotective effects following cerebral ischemia/reperfusion injury by inhibiting autophagy via the PI3K/Akt pathway. _h[electronic resource] |
| 260 |
_bBrain research _c03 2019 |
||
| 300 |
_a124-132 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aAutophagy _xphysiology |
| 650 | 0 | 4 |
_aBone Marrow _xmetabolism |
| 650 | 0 | 4 |
_aBrain Ischemia _xmetabolism |
| 650 | 0 | 4 |
_aCell Death _xdrug effects |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aInfarction, Middle Cerebral Artery _xpathology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMesenchymal Stem Cell Transplantation _xmethods |
| 650 | 0 | 4 |
_aMesenchymal Stem Cells _xmetabolism |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xmetabolism |
| 650 | 0 | 4 |
_aPhosphatidylinositol 3-Kinases _xmetabolism |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xmetabolism |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReperfusion Injury _xmetabolism |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aTOR Serine-Threonine Kinases _xmetabolism |
| 700 | 1 | _aZeng, Qing | |
| 700 | 1 | _aHuang, Guozhi | |
| 700 | 1 | _aLin, Yiqiu | |
| 700 | 1 | _aLin, Hongxin | |
| 700 | 1 | _aLiu, Wei | |
| 700 | 1 | _aLu, Pengcheng | |
| 773 | 0 |
_tBrain research _gvol. 1707 _gp. 124-132 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.brainres.2018.11.018 _zAvailable from publisher's website |
| 999 |
_c29063618 _d29063618 |
||